MA
INSM icon

Montag & Associates’s Insmed INSM Stock Holding History

Montag & Associates’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54K Sell
14
-2
-13% -$242 ﹤0.01% 893
2026
Q1 		$2.61K Hold
16
– – ﹤0.01% 827
2025
Q4 		$2.77K Sell
16
-2
-11% -$365 ﹤0.01% 845
2025
Q3 		$2.6K Sell
18
-500
-97% -$61.3K ﹤0.01% 889
2025
Q2 		$52.1K Buy
518
+1
+0.2% +$76 ﹤0.01% 580
2025
Q1 		$39.4K Buy
517
+17
+3% +$1.3K ﹤0.01% 653
2024
Q4 		$34.5K Hold
500
– – ﹤0.01% 658
2024
Q3 		$36.5K Sell
500
-131
-21% -$9.67K ﹤0.01% 650
2024
Q2 		$42.3K Buy
+631
New +$24.5K ﹤0.01% 616

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Montag & Associates's INSM Position: Q2 2026 in Review

Montag & Associates reduced its Insmed (INSM) stake by 13% in Q2 2026, selling an estimated $242 and leaving 14 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #893.

Montag & Associates first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $52.1K in Q2 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Montag & Associates held 14 shares of Insmed worth $1.54K as of Q2 2026.
  • Montag & Associates sold 2 Insmed shares in Q2 2026, an estimated $242.
  • Insmed made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #893 holding.
  • Montag & Associates first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Montag & Associates's Insmed position peaked at $52.1K in Q2 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.